These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 25999115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous?
    Casella G, Resciniti E, Gallo P.
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e21-e25. PubMed ID: 29045308
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
    Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL, Parvataneni R, Maehara A, Généreux P, Mehran R, Stone GW.
    JACC Cardiovasc Interv; 2015 Dec 28; 8(15):1978-1987. PubMed ID: 26738669
    [Abstract] [Full Text] [Related]

  • 6. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.
    Hermiller JB, Krucoff MW, Kereiakes DJ, Windecker S, Steg PG, Yeh RW, Cohen DJ, Cutlip DE, Massaro JM, Hsieh WH, Mauri L, DAPT Study Investigators.
    JACC Cardiovasc Interv; 2016 Jan 25; 9(2):138-47. PubMed ID: 26793956
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
    Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):395-405. PubMed ID: 22109961
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
    Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L, DAPT Study Investigators.
    JACC Cardiovasc Interv; 2015 Oct 01; 8(12):1552-62. PubMed ID: 26493248
    [Abstract] [Full Text] [Related]

  • 10. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land?
    Naspro R, Rossini R, Musumeci G, Gadda F, Pozzo LF.
    Eur Urol; 2013 Jul 01; 64(1):101-5. PubMed ID: 23428067
    [No Abstract] [Full Text] [Related]

  • 11. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW, Kang SH, Park JJ, Yang HM, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS.
    JACC Cardiovasc Interv; 2013 Sep 01; 6(9):932-42. PubMed ID: 24050860
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V, Cuisset T, Chenu P, Vrolix M, Martinez C, Dens J, Gach O, Boland J, Claeys MJ, Magne J, Barbato E, Wijns W.
    EuroIntervention; 2014 Jun 01; 10(2):204-11. PubMed ID: 24952058
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Mishra A, Singh M, Acker WW, Kamboj S, Sporn D, Stapleton D, Kaluski E.
    J Cardiovasc Pharmacol; 2019 Aug 01; 74(2):82-90. PubMed ID: 31306367
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.
    Li J, Ju J, Chen Z, Liu J, Lu F, Gao R, Xu H.
    Trials; 2018 Feb 07; 19(1):93. PubMed ID: 29415754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.